• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝扎贝特以 CLOCK 依赖性的生物钟方式诱导纤溶酶原激活物抑制剂-1 基因表达。

Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner.

机构信息

Biological Clock Research Group, Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba, Ibaraki, Japan.

出版信息

Mol Pharmacol. 2010 Jul;78(1):135-41. doi: 10.1124/mol.110.064402. Epub 2010 Apr 16.

DOI:10.1124/mol.110.064402
PMID:20400680
Abstract

A functional interaction between peroxisome proliferator-activated receptor alpha (PPARalpha) and components of the circadian clock has been suggested, but whether these transcriptional factors interact to regulate the expression of their target genes remains obscure. Here we used a PPARalpha ligand, bezafibrate, to search for PPARalpha-regulated genes that are expressed in a CLOCK-dependent circadian manner. Microarray analyses using hepatic RNA isolated from bezafibrate treated-wild type, Clock mutant (Clk/Clk), and PPARalpha-null mice revealed that 136 genes are transcriptionally regulated by PPARalpha in a CLOCK-dependent manner. Among them, we focused on the plasminogen activator inhibitor-1 (PAI-1) gene, because its expression typically shows circadian variation, and it has transcriptional response elements for both PPAR and CLOCK. The bezafibrate-induced expression of PAI-1 mRNA was attenuated in Clk/Clk mice and in PPARalpha-null mice. The protein levels of PPARalpha were reduced in Clk/Clk hepatocytes. However, the overexpression of PPARalpha could not rescue bezafibrate-induced PAI-1 expression in Clk/Clk hepatocytes, suggesting that impaired bezafibrate-induced PAI-1 expression in Clk/Clk mice is not due to reduced PPARalpha expression. Luciferase reporter and chromatin immunoprecipitation analyses using primary hepatocytes demonstrated that DNA binding of both PPARalpha and CLOCK is essential for bezafibrate-induced PAI-1 gene expression. Pull-down assays in vitro showed that both PPARalpha and its heterodimerized partner retinoic acid receptor-alpha can serve as potential interaction targets of CLOCK. The present findings revealed that molecular interaction between the circadian clock and the lipid metabolism regulator affects the bezafibrate-induced gene expression.

摘要

过氧化物酶体增殖物激活受体α(PPARα)与生物钟成分之间存在功能相互作用,但这些转录因子是否相互作用以调节其靶基因的表达尚不清楚。在这里,我们使用 PPARα 配体 bezafibrate 来搜索以 CLOCK 依赖性节律方式表达的 PPARα 调节的基因。使用来自 bezafibrate 处理的野生型、Clock 突变(Clk/Clk)和 PPARα 缺失小鼠的肝 RNA 进行微阵列分析,揭示了 136 个基因受 PPARα 以 CLOCK 依赖性方式转录调节。其中,我们重点关注纤溶酶原激活物抑制剂-1(PAI-1)基因,因为其表达通常表现出昼夜节律变化,并且具有 PPAR 和 CLOCK 的转录反应元件。在 Clk/Clk 小鼠和 PPARα 缺失小鼠中,bezafibrate 诱导的 PAI-1 mRNA 表达减弱。Clk/Clk 肝细胞中的 PPARα 蛋白水平降低。然而,PPARα 的过表达不能挽救 Clk/Clk 肝细胞中 bezafibrate 诱导的 PAI-1 表达,表明 Clk/Clk 小鼠中受损的 bezafibrate 诱导的 PAI-1 表达不是由于 PPARα 表达减少所致。使用原代肝细胞进行的荧光素酶报告基因和染色质免疫沉淀分析表明,PPARα 和 CLOCK 的 DNA 结合对于 bezafibrate 诱导的 PAI-1 基因表达都是必需的。体外下拉测定表明,PPARα 及其异二聚体伙伴视黄酸受体-α都可以作为 CLOCK 的潜在相互作用靶标。本研究结果表明,生物钟和脂质代谢调节剂之间的分子相互作用会影响 bezafibrate 诱导的基因表达。

相似文献

1
Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner.贝扎贝特以 CLOCK 依赖性的生物钟方式诱导纤溶酶原激活物抑制剂-1 基因表达。
Mol Pharmacol. 2010 Jul;78(1):135-41. doi: 10.1124/mol.110.064402. Epub 2010 Apr 16.
2
Proxisome proliferator-activated receptor-α mediates high-fat, diet-enhanced daily oscillation of plasminogen activator inhibitor-1 activity in mice.过氧化物酶体增殖物激活受体-α介导高脂饮食增强小鼠纤溶酶原激活物抑制剂-1 活性的日波动。
Chronobiol Int. 2010 Oct;27(9-10):1735-53. doi: 10.3109/07420528.2010.515324.
3
PPARα deficiency augments a ketogenic diet-induced circadian PAI-1 expression possibly through PPARγ activation in the liver.过氧化物酶体增殖物激活受体 α 缺乏增强生酮饮食诱导的昼夜节律性纤溶酶原激活物抑制剂 1 表达,可能通过肝脏中过氧化物酶体增殖物激活受体 γ 的激活。
Biochem Biophys Res Commun. 2010 Oct 15;401(2):313-8. doi: 10.1016/j.bbrc.2010.09.060. Epub 2010 Sep 18.
4
PPARalpha is a potential therapeutic target of drugs to treat circadian rhythm sleep disorders.过氧化物酶体增殖物激活受体α(PPARα)是治疗昼夜节律性睡眠障碍药物的潜在治疗靶点。
Biochem Biophys Res Commun. 2007 Jun 8;357(3):679-82. doi: 10.1016/j.bbrc.2007.04.002. Epub 2007 Apr 9.
5
CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor alpha (PPARalpha) in mice.生物钟基因(CLOCK)参与小鼠过氧化物酶体增殖物激活受体α(PPARα)的昼夜转激活过程。
Biochem J. 2005 Mar 15;386(Pt 3):575-81. doi: 10.1042/BJ20041150.
6
Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver.在小鼠肝脏中,过氧化物酶体增殖物激活受体α(PPARα)的激活可诱导成纤维细胞生长因子21(FGF21)的昼夜节律表达。
FEBS Lett. 2008 Oct 29;582(25-26):3639-42. doi: 10.1016/j.febslet.2008.09.046. Epub 2008 Oct 7.
7
Circadian clock molecules CLOCK and CRYs modulate fibrinolytic activity by regulating the PAI-1 gene expression.昼夜节律时钟分子CLOCK和CRYs通过调节PAI-1基因表达来调节纤溶活性。
J Thromb Haemost. 2006 Nov;4(11):2478-85. doi: 10.1111/j.1538-7836.2006.02210.x. Epub 2006 Sep 13.
8
Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.在过氧化物酶体增殖物激活受体α激动剂处理的小鼠原代肝细胞中差异表达的基因。
BMC Bioinformatics. 2006 Sep 6;7 Suppl 2(Suppl 2):S18. doi: 10.1186/1471-2105-7-S2-S18.
9
Influence of CLOCK on cytotoxicity induced by diethylnitrosamine in mouse primary hepatocytes.CLOCK 对二乙基亚硝胺诱导的小鼠原代肝细胞毒性的影响。
Toxicology. 2011 Feb 27;280(3):144-51. doi: 10.1016/j.tox.2010.12.005. Epub 2010 Dec 15.
10
Circadian expression of plasminogen activator inhibitor-1 in angiotensin II type 1a receptor knockout mice.血管紧张素II 1a型受体基因敲除小鼠中纤溶酶原激活物抑制剂-1的昼夜节律表达
Clin Exp Hypertens. 2005 Feb-Apr;27(2-3):159-68.

引用本文的文献

1
Crosstalk of hepatocyte nuclear factor 4a and glucocorticoid receptor in the regulation of lipid metabolism in mice fed a high-fat-high-sugar diet.高脂高糖饮食诱导的小鼠肝脏中肝细胞核因子 4a 与糖皮质激素受体的对话及其对脂代谢的调控
Lipids Health Dis. 2022 May 25;21(1):46. doi: 10.1186/s12944-022-01654-6.
2
GC-MS Profile of Hua-Feng-Dan and RNA-Seq Analysis of Induced Adaptive Responses in the Liver.华风丹的气相色谱-质谱联用分析及肝脏诱导适应性反应的RNA测序分析
Front Pharmacol. 2022 Mar 8;13:730318. doi: 10.3389/fphar.2022.730318. eCollection 2022.
3
PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target.
PAI-1 在糖尿病中的作用:病理生理学及作为治疗靶点的角色。
Int J Mol Sci. 2021 Mar 20;22(6):3170. doi: 10.3390/ijms22063170.
4
Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: The roles of PAI-1 and obesity on stroke.纤溶酶原激活物抑制剂将肥胖与血栓性脑血管疾病联系起来:纤溶酶原激活物抑制剂-1(PAI-1)和肥胖在中风中的作用。
Metab Brain Dis. 2017 Jun;32(3):667-673. doi: 10.1007/s11011-017-0007-3. Epub 2017 Apr 4.
5
PAI-1 Inhibition - Another Therapeutic Option for Cardiovascular Protection.纤溶酶原激活物抑制剂-1抑制作用——心血管保护的另一种治疗选择
Maedica (Bucur). 2015 Jun;10(2):147-152.